Literature DB >> 9061110

Epidural analgesia following upper abdominal surgery: United Kingdom practice.

T M Cook1, J M Eaton, A P Goodwin.   

Abstract

BACKGROUND: Epidural Analgesia (EA) may be used to provide pain relief after upper abdominal surgery. A variety of drugs and combinations may be used. Potential side effects lead some to believe EA should be restricted to high care areas.
METHOD: The use of EA following upper abdominal surgery is surveyed in 214 hospitals in the United Kingdom by means of a postal questionnaire.
RESULTS: Sixty-seven percent use EA frequently and 3% not at all. The low thoracic site is the most commonly used, by 65%. Forty-eight percent use a combination of sites. EA is most frequently achieved using a mixture of an opioid and a local anaesthetic (97%). No other agents are used. Fentanyl and diamorphine are the opioids used most widely (61% and 52% departments, respectively) in combination with local anaesthetic. Subcutaneous heparin is regularly used in 89% of departments. In 43%, the epidural is sited shortly after administering heparin. Use of EA is restricted solely to intensive or high-care units in 46% of hospitals. In 82% of departments, EA is continued for up to 72 h. Ninety-six percent of departments use continuous epidural infusions in the post-operative period. Adjunct analgesia includes non-steroidal anti-inflammatory drugs in 50% of departments. An anaesthetist supervises EA in 89% of hospitals. EA is considered to be the best mode of analgesia available by 80% of respondents.
CONCLUSION: EA is widely used in the United Kingdom following upper abdominal surgery. A degree of consensus exists on the choice of drug types, their method of administration and duration. There is no consensus as to whether the technique should be used on a general ward, which opioid should be used or the timing of heparin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061110     DOI: 10.1111/j.1399-6576.1997.tb04608.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

Review 1.  Paravertebral block versus thoracic epidural for patients undergoing thoracotomy.

Authors:  Joyce H Y Yeung; Simon Gates; Babu V Naidu; Matthew J A Wilson; Fang Gao Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-02-21

2.  The effect of anaesthetist grade and frequency of insertion on epidural failure: a service evaluation in a United Kingdom teaching hospital.

Authors:  Thomas P Heinink; Benjamin G Baker; Victoria F Yates; Dorothea C Addison; John P Williams
Journal:  BMC Anesthesiol       Date:  2015-01-21       Impact factor: 2.217

3.  Thoracic Epidural analgesia versus Rectus Sheath Catheters for open midline incisions in major abdominal surgery within an enhanced recovery programme (TERSC): study protocol for a randomised controlled trial.

Authors:  Kate M Wilkinson; Anton Krige; Sarah G Brearley; Steven Lane; Michael Scott; Anthony C Gordon; Gordon L Carlson
Journal:  Trials       Date:  2014-10-21       Impact factor: 2.279

4.  Analgesia in post-thoracotomy patients: Comparison between thoracic epidural and thoracic paravertebral blocks.

Authors:  Maitreyee Mukherjee; Anupam Goswami; Sampa Dutta Gupta; Debabrata Sarbapalli; Ranabir Pal; Sumit Kar
Journal:  Anesth Essays Res       Date:  2010 Jul-Dec

5.  Randomised controlled pilot study to investigate the effectiveness of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain: TOPIC feasibility study protocol.

Authors:  Joyce Yeung; Teresa Melody; Amy Kerr; Babu Naidu; Lee Middleton; Kostas Tryposkiadis; Jane Daniels; Fang Gao
Journal:  BMJ Open       Date:  2016-12-01       Impact factor: 2.692

Review 6.  Pain relief following thoracic surgical procedures: A literature review of the uncommon techniques.

Authors:  Tariq Alzahrani
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

7.  A comparison between thoracic epidural analgesia and rectus sheath catheter analgesia after open midline major abdominal surgery: randomized clinical trial.

Authors:  Anton Krige; Sarah G Brearley; Céu Mateus; Gordon L Carlson; Steven Lane
Journal:  BJS Open       Date:  2022-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.